American Association for Cancer Research

Table 3

Univariate analysis of age, clinical stage, histological type, histological grade, and Skp2 expression status for overall survival in ovarian adenocarcinoma patients

Factors	P ^a
Age (<50 yrs vs. >51 yrs)	0.0026
Clinical stage (stage I vs. stage II/III/IV)	<0.0001
Histological grade (grade 1 vs. grade 2/3)	0.0018
Skp2 expression^b
Negative vs. partial positive vs. diffuse positive	0.0102
Negative vs. partial or diffuse positive	0.0365
Negative or partial positive vs. diffuse positive	0.0035

Factors	P ^a
Age (<50 yrs vs. >51 yrs)	0.0026
Clinical stage (stage I vs. stage II/III/IV)	<0.0001
Histological grade (grade 1 vs. grade 2/3)	0.0018
Skp2 expression^b
Negative vs. partial positive vs. diffuse positive	0.0102
Negative vs. partial or diffuse positive	0.0365
Negative or partial positive vs. diffuse positive	0.0035

Log-rank test.

Skp2 expression partial positive, 5–25% positive tumor cell staining; diffuse positive, more than 25% positive tumor cell staining.

View Large

This Feature Is Available To Subscribers Only